Adam L. Cohen

10.0k citations

138 papers · 3.6k indexed · 1 hit paper · h-index 34

Epidemiology top 1%
Infectious Diseases top 2%
General Health Professions top 5%
Health top 2%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Stefano Tempia Cheryl Cohen Sibongile Walaza Shabir A. Madhi Jocelyn Moyes Marietjie Venter Frederick P. Rivara Heather McPhillips
Topics: Respiratory viral infections research (69 papers)Pneumonia and Respiratory Infections (64 papers)Influenza Virus Research Studies (58 papers)
Cited by: Epidemiology Microbiology Modeling and Simulation
Journals: PLoS ONE PEDIATRICS Clinical Infectious Diseases
Partner nations: United States South Africa Switzerland

In The Last Decade

Adam L. Cohen

135 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

2024 37 citations Miwako Kobayashi, Ryan Gierke et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by Adam L. Cohen

Since Specialization

Citations

This map shows the geographic impact of Adam L. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam L. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam L. Cohen more than expected).

Fields of papers citing papers by Adam L. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam L. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam L. Cohen. The network helps show where Adam L. Cohen may publish in the future.

Co-authorship network of co-authors of Adam L. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Adam L. Cohen. A scholar is included among the top collaborators of Adam L. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam L. Cohen. Adam L. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines 2025 ·The Journal of Infectious Diseases ·Laura King,Kristin L. Andrejko,Miwako Kobayashi,(unknown),Adam L. Cohen,Wesley H. Self,(unknown),Cynthia G. Whitney,Adrienne Baughman,(unknown),Carlos G. Grijalva,Jessica Traenkner,Nadine Rouphael,Joseph A. Lewnard	0
2	2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults 2025 ·Clinical Infectious Diseases ·Jeffrey A. Linder,Michael E. Watson,Michael R. Wessels,(unknown),Adam L. Cohen,Jennifer Dien Bard,Güliz Erdem,Christopher J. Gregory,Athena P. Kourtis,Judith M. Martin,A. Brian Mochon,Daniel J. Shapiro,Ryan W. Stevens,(unknown),Miriam B. Barshak	0
3	Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use — Two Cruise Ships, November 2022–July 2024 2024 ·MMWR Morbidity and Mortality Weekly Report ·Sooji Lee,Chris Edens,Troy Ritter,Luis O. Rodriguez,Kara Tardivel,Natalia A. Kozak‐Muiznieks,Melisa J. Willby,(unknown),Adam L. Cohen,Jessica C. Smith	1
4	Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 – 2018 2024 ·BMC Infectious Diseases ·Jocelyn Moyes,Stefano Tempia,Sibongile Walaza,Adam L. Cohen,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Halima Dawood,Ebrahim Variava,Kathleen Kahn,Shabir A. Madhi,Cheryl Cohen	1
5	Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes 2024 ·The Journal of Infectious Diseases ·Laura King,Kristin L. Andrejko,Sarah Kabbani,Sara Y. Tartof,Lauri A. Hicks,Adam L. Cohen,Miwako Kobayashi,Joseph A. Lewnard	3
6	Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study 2024 ·Vaccine ·Kristin L. Andrejko,Ryan Gierke,Jemma V. Rowlands,Jennifer B. Rosen,Ann Thomas,(unknown),María Rosales,(unknown),William Schaffner,Corinne Holtzman,Meghan Barnes,Monica M. Farley,Lee H. Harrison,Lesley McGee,Sopio Chochua,Jennifer R. Verani,Adam L. Cohen,Tamara Pilishvili,Miwako Kobayashi	15
7	The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016 2023 ·International Journal of Infectious Diseases ·Jocelyn Moyes,Stefano Tempia,Sibongile Walaza,Meredith McMorrow,Adam L. Cohen,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Halima Dawood,Ebrahim Variava,Kathleen Kahn,Shabir A. Madhi,Cheryl Cohen	4
8	The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–2015 2022 ·Influenza and Other Respiratory Viruses ·Stefano Tempia,Jocelyn Moyes,Adam L. Cohen,Sibongile Walaza,Meredith McMorrow,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Halima Dawood,Ebrahim Variava,Cheryl Cohen	13
9	Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009–2013 2021 ·PLoS ONE ·Oluwatosin Ayeni,Sibongile Walaza,Stefano Tempia,Michelle J. Groome,Kathleen Kahn,Shabir A. Madhi,Adam L. Cohen,Jocelyn Moyes,Marietjie Venter,Marthi Pretorius,Florette K. Treurnicht,Orienka Hellferscee,Anne von Gottberg,Nicole Wolter,Cheryl Cohen	4
10	Influenza economic burden among potential target risk groups for immunization in South Africa, 2013–2015 2020 ·Vaccine ·Stefano Tempia,Jocelyn Moyes,Adam L. Cohen,Sibongile Walaza,Meredith McMorrow,Ijeoma Edoka,(unknown),Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Johanna M. McAnerney,Halima Dawood,Ebrahim Variava,Cheryl Cohen	4
11	Influenza and tuberculosis co‐infection: A systematic review 2019 ·Influenza and Other Respiratory Viruses ·Sibongile Walaza,Cheryl Cohen,Stefano Tempia,Jocelyn Moyes,(unknown),Shabir A. Madhi,Meredith McMorrow,Adam L. Cohen	37
12	The performance of different case definitions for severe influenza surveillance among HIV-infected and HIV-uninfected children aged <5 years in South Africa, 2011–2015 2019 ·PLoS ONE ·(unknown),Stefano Tempia,Adam L. Cohen,Sibongile Walaza,Lazarus Kuonza,Alfred Musekiwa,Anne von Gottberg,Orienka Hellferscee,Nicole Wolter,Florette K. Treurnicht,Jocelyn Moyes,Fathima Naby,Omphile Mekgoe,Cheryl Cohen	2
13	Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015 2019 ·Influenza and Other Respiratory Viruses ·Stefano Tempia,Jocelyn Moyes,Adam L. Cohen,Sibongile Walaza,Ijeoma Edoka,Meredith McMorrow,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,(unknown),Johanna M. McAnerney,Halima Dawood,Ebrahim Variava,Cheryl Cohen	28
14	Replacement of neuraminidase inhibitor‐susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009‐2013, South Africa 2018 ·Influenza and Other Respiratory Viruses ·Florette K. Treurnicht,Amelia Buys,Stefano Tempia,(unknown),Adam L. Cohen,Sibongile Walaza,Allison Glass,(unknown),Johanna M. McAnerney,Lucille Blumberg,Cheryl Cohen,Marietjie Venter	7
15	The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza‐associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013‐2015 2017 ·Influenza and Other Respiratory Viruses ·Stefano Tempia,Sibongile Walaza,Jocelyn Moyes,Adam L. Cohen,Claire von Mollendorf,Meredith McMorrow,(unknown),Florette K. Treurnicht,Marietjie Venter,Marthi Pretorius,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,(unknown),Johanna M. McAnerney,Halima Dawood,Ebrahim Variava,Shabir A. Madhi,Cheryl Cohen	17
16	Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals 2017 ·PLoS ONE ·Jazmin Duque,(unknown),David A. Clark,(unknown),(unknown),Cheryl Cohen,Sibongile Walaza,Stefano Tempia,(unknown),(unknown),Marc‐Alain Widdowson,Meredith McMorrow,Adam L. Cohen	11
17	Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting 2017 ·Journal of Infection ·Jocelyn Moyes,Sibongile Walaza,Marthi Pretorius,Michelle J. Groome,Anne von Gottberg,Nicole Wolter,Sumayya Haffejee,Ebrahim Variava,Adam L. Cohen,Stefano Tempia,Kathleen Kahn,Halima Dawood,Marietjie Venter,Cheryl Cohen,Shabir A. Madhi	28
18	The national burden of influenza‐associated severe acute respiratory illness hospitalization in Zambia, 2011‐2014 2017 ·Influenza and Other Respiratory Viruses ·Andros Theo,Stefano Tempia,Adam L. Cohen,(unknown),(unknown),(unknown),Mwaka Monze	25
19	Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa 2015 ·BMC Infectious Diseases ·Stefano Tempia,Nicole Wolter,Cheryl Cohen,Sibongile Walaza,Claire von Mollendorf,Adam L. Cohen,Jocelyn Moyes,Linda de Gouveia,Susan Nzenze,Florette K. Treurnicht,Marietjie Venter,Michelle J. Groome,Shabir A. Madhi,Anne von Gottberg	15
20	Economic Analysis of Prevaccination Serotesting Compared With Presumptive Immunization for Polio, Diphtheria, and Tetanus in Internationally Adopted and Immigrant Infants 2006 ·PEDIATRICS ·Adam L. Cohen,David L. Veenstra	12

About Adam L. Cohen

Adam L. Cohen is a scholar working on Epidemiology, Health and Microbiology, having authored 138 papers that have together received 3.6k indexed citations. Recurring topics across this work include Respiratory viral infections research (69 papers), Pneumonia and Respiratory Infections (64 papers) and Influenza Virus Research Studies (58 papers). The work is most often cited by research in Epidemiology (2.2k citations), Microbiology (356 citations) and Modeling and Simulation (216 citations). Adam L. Cohen has collaborated with scholars based in United States, South Africa and Switzerland. Frequent co-authors include Stefano Tempia, Cheryl Cohen, Sibongile Walaza, Shabir A. Madhi, Jocelyn Moyes, Marietjie Venter, Frederick P. Rivara, Heather McPhillips, Robert Davis and Edgar K. Marcuse. Their work appears in journals such as PLoS ONE, PEDIATRICS and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact